Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
FABP1
REST API REST API
Homo sapiens
FABP1 is differentially expressed in 157 experiments: 87 organism parts: liver, kidney, ... (85 more);, 157 disease states: normal, colon carcinoma, ... (155 more);, 32 cell types 149 cell lines 14 compound treatments and 61 other conditions.
Synonyms L-FABP
Orthologs Q90WA9_CHICK (Gallus gallus)   F6RM44_CIOIN (Ciona intestinalis)   Fabp1 (Mus musculus)   fabp1a (Danio rerio)   FABPL_BOVIN (Bos taurus)   fabp1b.1 (Danio rerio)   Fabp1 (Rattus norvegicus)   fabp1b.2 (Danio rerio)   fabp1 (Xenopus laevis)   Q95KW5_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term transporter activity, cytosol, transport, apical cortex, cytoplasm, positive regulation of cell proliferation, lipid binding, phospholipid binding, nucleus, fatty acid binding, chromatin binding, binding, organ morphogenesis, intestinal absorption, peroxisomal matrix, drug binding, long-chain fatty acid transport, positive regulation of hydrolase activity, long-chain fatty acid transporter activity, bile acid binding, positive regulation of fatty acid beta-oxidation
InterPro Term Fatty_acid-bd, Lipocln_cytosolic_FA-bd_dom
UniProt Accession P07148, Q6FGL7, A8MW49
Search EB-eye ENSG00000163586
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-1577, E-MTAB-24, ... (22 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-18005, E-GEOD-2450, E-GEOD-24147, E-GEOD-19480, E-MTAB-62, ... (20 experiments)

Factor Value U/D Experiments
MDA468
2
E-MEXP-440, E-MTAB-62
MCF-7
2
E-GEOD-5823, E-GEOD-20081
SNU16
2
E-MTAB-37, E-GEOD-15460
SW480
2
E-MEXP-1014, E-GEOD-18005
T84
2
E-GEOD-1474, E-MTAB-37
primary culture
2
E-GEOD-2450, E-GEOD-1657
143 more value(s).


Cell type

studied in E-GEOD-10797, E-GEOD-18811, E-GEOD-22373, E-MTAB-25, E-GEOD-20033, ... (17 experiments)

Factor Value U/D Experiments
monocyte
2
E-GEOD-22373, E-GEOD-11755
M1 macrophage
1
E-GEOD-5099
Leukocytes
1
E-GEOD-21909
human embryonic stem cell
1
E-GEOD-20033
chondrocyte
1
E-TABM-130
LCC
1
E-GEOD-19188
26 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1869, E-GEOD-1577, ... (33 experiments)

Factor Value U/D Experiments
colon carcinoma
1
3
E-MTAB-37, E-GEOD-3726, E-MTAB-62, E-MTAB-57
melanoma
2
E-MTAB-62, E-MTAB-37
hepatocellular adenoma
2
E-TABM-36, E-MTAB-62
hepatocellular carcinoma
2
E-MTAB-62, E-MTAB-37
prostate carcinoma
2
E-MTAB-62, E-MEXP-2034
nephrosclerosis
1
E-GEOD-20602
151 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-6907, E-GEOD-412, E-GEOD-2292, E-MEXP-1335, ... (10 experiments)

Factor Value U/D Experiments
not specified
1
E-GEOD-20081
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
unknown
1
E-GEOD-7307
glucose
1
E-MEXP-941
control
31
1
E-GEOD-3284
none
1
E-GEOD-412
8 more value(s).


Biopsy tissue

studied in E-GEOD-5851

Factor Value U/D Experiments
colon
1
E-GEOD-5851


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-TABM-36, E-GEOD-21374, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-3140, E-TABM-145, E-GEOD-7307, ... (6 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Family relationship
studied in E-MEXP-1425

Genotype
studied in E-GEOD-2466, E-GEOD-17476, E-MEXP-421, E-TABM-321, E-GEOD-17347 ... (5 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-1446

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-21653, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-TABM-325, E-TABM-176, E-MEXP-2069, E-TABM-666, E-TABM-15, ... (20 experiments)

Infection
studied in E-GEOD-12254, E-GEOD-980

Injury
studied in E-GEOD-19743

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-AFMX-1, E-TABM-84

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-1309, E-GEOD-1657

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-1343

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-1509, E-MEXP-101

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-2466, E-GEOD-7540, E-GEOD-7307

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271

Processing time: 0.496 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM